Intesti-bacteriophage
Trade name
Intesti
Dosage form
Solution for oral and rectal administration
Shelf life
2 years
Manufacturer
НПО "Микроген", Россия, 614089, Пермский край, г. Пермь, ул. Братская, д. 177; and 44, Gruzinskaya str., Nizhny Novgorod, Nizhny Novgorod region, 603950 Russia
Presentation
Solution for oral and rectal administration in 20 ml or 100 ml vials. Four or ten 20 ml vials or one 100 ml vial in each cardboard package with a package insert.
Ingredients
The preparation is a mixture of sterile filtrates of phage lysates of Shigellaflexneri 1, 2, 3, 4, 6 serovariants, Shigellasonnei, SalmonellaparatyphiA, SalmonellaparatyphiB, Salmonellatyphimurium, Salmonellainfantis, Salmonellacholeraesuis, Salmonellaoranienburg, Salmonellaenteritidis, enteropathogenic Escherichiacoli of various serogroups which play a key role in the ethiology of enteral deseases, Proteusvulgaris, Proteusmirabilis, Enterococcus, Staphylococcus, Pseudomonasaeruginosa.
Excipients:
Preservative - 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (estimated content);
or 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (equal to 8-hydroxyquinoline sulfate).
Indications
Treatment and prevention of diseases of the gastrointestinal tract caused by bacteria of dysentery, Salmonella, Escherichia coli, Proteus, enterococci, staphylococci, Pseudomonas aeruginoza or a combination thereof.
- bacterial dysentery;
- salmonellosis;
- dyspepsia;
- disbacteriosis;
- enterocolitis, colitis.
An important condition for the effective phage therapy is a preliminary determination of the phage sensitivity of the pathogen.